ClosetInvetor, The 75 patient trial started last
Post# of 148179
(Total Views: 650)
Posted On: 05/05/2020 7:47:01 AM
Re: ClosetInvestor #32054
ClosetInvetor,
I believe they are referring to the trial here in USA. They just copied-and-pasted. You are right, it would seem that the trial has been launched locally in the newspaper publication county but I don't think so.
In reference to end of may for full enrollment, I think CYDY should, of course, try and accelerate the enrollment. This trial will finished before the Severe one and will give credibility and public recognition to Leronlimab.
NP said two things in the latest Proactive: there is the possibility that the enrollment is finalized before end of May and the results available end of May. He is being cautious as the speed of enrollment is now in the hands of the trial sites. However, as these augment the rate of enrollment will go up geometrically.
The second point he made is that at the end of P2 Mild-to-Moderate FDA will have proof of safety and efficacy and mentioned: "this is what the FDA needs for approval".
So, we don't know when the recruitment will be completed, obviously we all hope sooner that later. What it is CRITICAL are the results.
If we blow the p-number out of the water FDA will be under extreme pressure to bring Leronlimab to the market swiftly, and I mean EXTREME pressure.
One thing is to sing the praises in the oval office of a drug that helps to somewhat reduce the hospital stay if administered early (only) in a fudged, "open" trial and another to try and hide a drug that in a double-blinded trial demonstrated irreputable therapeutically benefit.
I say lets' get a 0.001 p-number !!!! Go CYDY !!!!
The prize will be huge !!!!!! Lives saved in the 100's of thousands (no exaggeration here)
Quote:
The 75 patient trial started last month and has already enrolled 35. The PR this morning said the company expects full enrollment by the end of May. Either that author of this article really didn’t pay attention to the details of the PR, or CYDY is starting another 75 patient phase 2 trial in the U.K. But I find it hard that we’d find out about an approved U.K. trial via a second rate online news organization instead of a PR or from NP.
I believe they are referring to the trial here in USA. They just copied-and-pasted. You are right, it would seem that the trial has been launched locally in the newspaper publication county but I don't think so.
In reference to end of may for full enrollment, I think CYDY should, of course, try and accelerate the enrollment. This trial will finished before the Severe one and will give credibility and public recognition to Leronlimab.
NP said two things in the latest Proactive: there is the possibility that the enrollment is finalized before end of May and the results available end of May. He is being cautious as the speed of enrollment is now in the hands of the trial sites. However, as these augment the rate of enrollment will go up geometrically.
The second point he made is that at the end of P2 Mild-to-Moderate FDA will have proof of safety and efficacy and mentioned: "this is what the FDA needs for approval".
So, we don't know when the recruitment will be completed, obviously we all hope sooner that later. What it is CRITICAL are the results.
If we blow the p-number out of the water FDA will be under extreme pressure to bring Leronlimab to the market swiftly, and I mean EXTREME pressure.
One thing is to sing the praises in the oval office of a drug that helps to somewhat reduce the hospital stay if administered early (only) in a fudged, "open" trial and another to try and hide a drug that in a double-blinded trial demonstrated irreputable therapeutically benefit.
I say lets' get a 0.001 p-number !!!! Go CYDY !!!!
The prize will be huge !!!!!! Lives saved in the 100's of thousands (no exaggeration here)
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼